Prediction of mild cognitive impairment using blood multi-omics data

Prediction of mild cognitive impairment using blood multi-omics data

Mild cognitive impairment (MCI) represents an initial phase of memory or other cognitive function decline and is viewed as an intermediary stage between normal aging and Alzheimer’s disease (AD), the most prevalent type of dementia. Individuals with MCI face a heightened risk of progressing to AD, a...

Full description

Saved in:
Bibliographic Details
Main Authors: Daniel Frank Zhang, Cigdem Sevim Bayrak, Qi Zeng, Minghui Wang, Bin Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-05-01
Series:Frontiers in Genetics
Subjects:
mild cognitive impairment
Alzheimer’s disease
machine learning
copy number variation
gene expression
Online Access:https://www.frontiersin.org/articles/10.3389/fgene.2025.1552063/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items